Mor A, Antonsen S, Kahlert J, Holsteen V, Jørgensen S, Holm-Pedersen J, Sørensen H T, Pedersen O, Ehrenstein V
Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Child and Adolescent Health Section, Department of Family and Employment, Municipality of Aalborg, Aalborg, Denmark.
Int J Obes (Lond). 2015 Oct;39(10):1450-5. doi: 10.1038/ijo.2015.129. Epub 2015 Jul 16.
BACKGROUND/OBJECTIVE: Prenatal exposure to antibacterials may permanently dysregulate fetal metabolic patterns via epigenetic pathways or by altering maternal microbiota. We examined the association of prenatal exposure to systemic antibacterials with overweight and obesity in schoolchildren.
SUBJECTS/METHODS: We conducted a prevalence study among Danish schoolchildren aged 7-16 years using data from routine school anthropometric evaluations conducted during 2002-2013. Prenatal exposure to antibacterials was ascertained by using maternal prescription dispensations and infection-related hospital admissions during pregnancy. We defined overweight and obesity among the children using standard age- and sex-specific cutoffs. We computed sex-specific adjusted prevalence ratios (aPRs) of overweight and obesity associated with exposure to prenatal antibacterials, adjusting for maternal age at delivery, marital status, smoking in pregnancy and multiple gestation; we also stratified the analyses by birth weight.
Among 9886 schoolchildren, 3280 (33%) had prenatal exposure to antibacterials. aPRs associated with the exposure were 1.26 (95% confidence interval (CI): 1.10-1.45) for overweight and 1.29 (95% CI: 1.03-1.62) for obesity. Among girls, aPRs were 1.16 (95% CI: 0.95-1.42) for overweight and 1.27 (95% CI: 0.89 to 1.82) for obesity. Among boys, aPRs were 1.37 (95% CI: 1.13-1.66) for overweight and 1.29 (95% CI: 0.96-1.73) for obesity. The aPR for overweight was higher among schoolchildren with birth weight <3500 g (aPR: 1.30, 95% CI: 1.05-1.61) than in schoolchildren with birth weight ⩾3500 g (aPR: 1.18, 95% CI: 0.95-1.46). Inversely, the association for obesity was higher among schoolchildren with birth weight ⩾3500 g (aPR: 1.35, 95% CI: 1.00-1.81) than among those who were <3500 g at birth (aPR: 1.16, 95% CI: 0.82-1.65).
Prenatal exposure to systemic antibacterials is associated with an increased risk of overweight and obesity at school age, and this association varies by birth weight.
背景/目的:孕期接触抗菌药物可能通过表观遗传途径或改变母体微生物群而永久性地失调胎儿代谢模式。我们研究了孕期全身性抗菌药物暴露与学龄儿童超重和肥胖之间的关联。
对象/方法:我们利用2002年至2013年期间学校常规人体测量评估的数据,对7至16岁的丹麦学龄儿童进行了一项患病率研究。通过使用孕期母亲的处方配药和与感染相关的住院情况来确定孕期抗菌药物暴露情况。我们使用标准的年龄和性别特异性临界值来定义儿童超重和肥胖。我们计算了与孕期抗菌药物暴露相关的超重和肥胖的性别特异性调整患病率比(aPRs),并对分娩时的母亲年龄、婚姻状况、孕期吸烟和多胎妊娠进行了调整;我们还按出生体重对分析进行了分层。
在9886名学龄儿童中,3280名(33%)有孕期抗菌药物暴露史。与暴露相关的超重aPRs为1.26(95%置信区间(CI):1.10 - 1.45),肥胖aPRs为1.29(95%CI:1.03 - 1.62)。在女孩中,超重aPRs为1.16(95%CI:0.95 - 1.42),肥胖aPRs为1.27(95%CI:0.89至1.82)。在男孩中,超重aPRs为1.37(95%CI:1.13 - 1.66),肥胖aPRs为1.29(95%CI:0.96 - 1.73)。出生体重<3500 g的学龄儿童超重的aPR(aPR:1.30,95%CI:1.05 - 1.61)高于出生体重⩾3500 g的学龄儿童(aPR:1.18,95%CI:0.95 - 1.46)。相反,出生体重⩾3500 g的学龄儿童肥胖的关联度(aPR:1.35,95%CI:1.00 - 1.81)高于出生时<3500 g的儿童(aPR:1.16,95%CI:0.82 - 1.65)。
孕期全身性抗菌药物暴露与学龄期超重和肥胖风险增加有关,且这种关联因出生体重而异。